David S. Kliman

Royal North Shore Hospital
Sydney, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

A randomized pilot trial comparing anti-thymocyte globulin with anti-thymocyte globulin plus post transplant cyclophosphamide for prophylaxis against acute and chronic graft versus host disease in matched donor hematopoietic cell transplants - a study from the Cell Therapy Transplant Canada/ Australasian Leukemia Lymphoma Group Consortium.

A randomized pilot trial comparing anti-thymocyte globulin with anti-thymocyte globulin plus post transplant cyclophosphamide for prophylaxis against acute and chronic graft versus host disease in matched donor hematopoietic cell transplants - a study from the Cell Therapy Transplant Canada/ Australasian Leukemia Lymphoma Group Consortium.

Journal: Bone marrow transplantation

Published: February 23, 2026

Voriconazole therapy and CYP2C19 phenotype: identifying patients who may need alternative antifungal therapy.

Voriconazole therapy and CYP2C19 phenotype: identifying patients who may need alternative antifungal therapy.

Journal: The Journal of antimicrobial chemotherapy

Published: October 26, 2025

Reply to: Reproducibility of Clinically Meaningful Change in Physical Capacity Tested by Online 6-Minute Walk Test.

Reply to: Reproducibility of Clinically Meaningful Change in Physical Capacity Tested by Online 6-Minute Walk Test.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 21, 2025

Integrating International Consensus Guidelines for Anticancer Drug Dosing in Kidney Dysfunction (ADDIKD) into everyday practice.

Integrating International Consensus Guidelines for Anticancer Drug Dosing in Kidney Dysfunction (ADDIKD) into everyday practice.

Journal: EClinicalMedicine

Published: December 11, 2024

Randomized Controlled Trial of a Virtually Delivered Exercise and Stress Management Program to Improve Physical Performance of Hematopoietic Cell Transplant Survivors.

Randomized Controlled Trial of a Virtually Delivered Exercise and Stress Management Program to Improve Physical Performance of Hematopoietic Cell Transplant Survivors.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: November 26, 2024

Preventing Allogeneic Stem Cell Transplant-Related Cardiovascular Dysfunction: ALLO-Active Trial.

Preventing Allogeneic Stem Cell Transplant-Related Cardiovascular Dysfunction: ALLO-Active Trial.

Journal: Circulation

Published: November 04, 2024

Aligning kidney function assessment in patients with cancer to global practices in internal medicine.

Aligning kidney function assessment in patients with cancer to global practices in internal medicine.

Journal: EClinicalMedicine

Published: August 15, 2024

Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years.

Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years.

Journal: Nature communications

Published: May 31, 2024

If we do not count it, it does not count: ethnicity in allogeneic haemopoietic stem cell transplant in Australia.

If we do not count it, it does not count: ethnicity in allogeneic haemopoietic stem cell transplant in Australia.

Journal: Internal medicine journal

Published: August 02, 2023

The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma.

The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma.

Journal: Blood

Published: June 01, 2023

Long-term outcomes of corticosteroid graft versus host disease prophylaxis in peripheral blood allogeneic haemopoietic stem cell transplant: a comparative cohort analysis.

Long-term outcomes of corticosteroid graft versus host disease prophylaxis in peripheral blood allogeneic haemopoietic stem cell transplant: a comparative cohort analysis.

Journal: Internal medicine journal

Published: December 23, 2022

Peripheral Blood CD34 Donor Chimerism has Greater Clinical Utility Than CD3 for Detecting Relapse after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome.

Peripheral Blood CD34 Donor Chimerism has Greater Clinical Utility Than CD3 for Detecting Relapse after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome.

Journal: Transplantation and cellular therapy

Published: December 09, 2022

Showing 1-12 of 31

Last Updated: 09/26/2026